These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15477297)

  • 21. Familial breast and ovarian cancers.
    Arai M; Utsunomiya J; Miki Y
    Int J Clin Oncol; 2004 Aug; 9(4):270-82. PubMed ID: 15375703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical significance of recognizing distinct morphologic and biologic features of hereditary breast cancer.
    Masood S
    Breast J; 2002; 8(2):69. PubMed ID: 11896749
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
    Pasacreta JV
    Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary Breast and ovarian cancer: providing personalized medicine.
    Tranin AS
    AWHONN Lifelines; 2005; 9(5):372-6. PubMed ID: 16359075
    [No Abstract]   [Full Text] [Related]  

  • 25. Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.
    Ann Intern Med; 2005 Sep; 143(5):I47. PubMed ID: 16144889
    [No Abstract]   [Full Text] [Related]  

  • 26. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
    Minion LE; Dolinsky JS; Chase DM; Dunlop CL; Chao EC; Monk BJ
    Gynecol Oncol; 2015 Apr; 137(1):86-92. PubMed ID: 25622547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
    Wolff TA; Wilson JE
    Am Fam Physician; 2006 Nov; 74(10):1759-60. PubMed ID: 17137007
    [No Abstract]   [Full Text] [Related]  

  • 28. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
    Nippert I; Schlegelberger B;
    Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary breast/ovarian cancer--pitfalls in genetic counseling.
    Dagan E; Gershoni-Baruch R
    Clin Genet; 2001 Oct; 60(4):310-3. PubMed ID: 11683778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics: predisposition and management.
    Legare RD
    Clin Obstet Gynecol; 2011 Mar; 54(1):180-90. PubMed ID: 21278518
    [No Abstract]   [Full Text] [Related]  

  • 31. Hereditary breast and ovarian cancer syndrome and issues in pediatric and adolescent practice.
    Herman JD; Appelbaum H
    J Pediatr Adolesc Gynecol; 2010 Aug; 23(4):253-8. PubMed ID: 20632459
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Missense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.
    Dombernowsky SL; Weischer M; Freiberg JJ; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2339-42. PubMed ID: 19661094
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
    Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
    Meindl A;
    Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.
    Evans DG; Lalloo F; Wallace A; Rahman N
    J Med Genet; 2005 Jul; 42(7):e39. PubMed ID: 15994864
    [No Abstract]   [Full Text] [Related]  

  • 38. Taking family history seriously.
    Burke W
    Ann Intern Med; 2005 Sep; 143(5):388-9. PubMed ID: 16144898
    [No Abstract]   [Full Text] [Related]  

  • 39. An overview of hereditary breast and ovarian cancer syndrome.
    Smith EC
    J Midwifery Womens Health; 2012; 57(6):577-584. PubMed ID: 23050669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing for breast and ovarian cancer: ethical, legal, and psychosocial considerations.
    Lessick M
    Nurs Womens Health; 2007 Aug; 11(4):390-9; quiz 400-1. PubMed ID: 17883756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.